TABLE 6D - INVALID PROCEDURE CODES
Procedure Code	Description	O.R.	MDC	MS-DRG
30233AZ^	Transfusion of Embryonic Stem Cells into Peripheral Vein, Percutaneous Approach	N**	PRE	016, 017
30243AZ^	Transfusion of Embryonic Stem Cells into Central Vein, Percutaneous Approach	N**	PRE	016, 017
X2KB317*	Bypass Right Radial Artery using Thermal Resistance Energy, Percutaneous Approach, New Technology Group 7	Y	05	361, 362
""			06	356, 357, 358
""			10	628, 629, 630
""			11	673, 674, 675
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
X2KC317*	Bypass Left Radial Artery using Thermal Resistance Energy, Percutaneous Approach, New Technology Group 7	Y	05	361, 362
""			06	356, 357, 358
""			10	628, 629, 630
""			11	673, 674, 675
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XD2G4V7*	Monitoring of Upper GI Oxygen Saturation, Percutaneous Endoscopic Approach, New Technology Group 7	N		
XD2G8V7*	Monitoring of Upper GI Oxygen Saturation, Via Natural or Artificial Opening Endoscopic, New Technology Group 7	N		
XD2H4V7*	Monitoring of Lower GI Oxygen Saturation, Percutaneous Endoscopic Approach, New Technology Group 7	N		
XD2H8V7*	Monitoring of Lower GI Oxygen Saturation, Via Natural or Artificial Opening Endoscopic, New Technology Group 7	N		
XRGA0R7*	Fusion of Thoracolumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7	Y	01	028, 029, 030
""			08	402, 426, 427, 428, 456, 457, 458
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XRGA3R7*	Fusion of Thoracolumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7	Y	01	028, 029, 030
""			08	402, 426, 427, 428, 456, 457, 458
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XRGA4R7*	Fusion of Thoracolumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7	Y	01	028, 029, 030
""			08	402, 426, 427, 428, 456, 457, 458
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XRGB0R7*	Fusion of Lumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7	Y	01	028, 029, 030
""			08	402, 426, 427, 428, 456, 457, 458
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XRGB3R7*	Fusion of Lumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7	Y	01	028, 029, 030
""			08	402, 426, 427, 428, 456, 457, 458
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XRGB4R7*	Fusion of Lumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7	Y	01	028, 029, 030
""			08	402, 426, 427, 428, 456, 457, 458
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XRGC0R7*	Fusion of 2 or more Lumbar Vertebral Joints using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7	Y	01	028, 029, 030
""			08	426, 427, 428, 447, 448, 456, 457, 458
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XRGC3R7*	Fusion of 2 or more Lumbar Vertebral Joints using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7	Y	01	028, 029, 030
""			08	426, 427, 428, 447, 448, 456, 457, 458
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XRGC4R7*	Fusion of 2 or more Lumbar Vertebral Joints using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7	Y	01	028, 029, 030
""			08	426, 427, 428, 447, 448, 456, 457, 458
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XRGD0R7*	Fusion of Lumbosacral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7	Y	01	028, 029, 030
""			08	402, 426, 427, 428, 456, 457, 458
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XRGD3R7*	Fusion of Lumbosacral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7	Y	01	028, 029, 030
""			08	402, 426, 427, 428, 456, 457, 458
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XRGD4R7*	Fusion of Lumbosacral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7	Y	01	028, 029, 030
""			08	402, 426, 427, 428, 456, 457, 458
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
XW00X27*	Introduction of Anacaulase-bcdb into Skin, External Approach, New Technology Group 7	N		
XW01397*	Introduction of Satralizumab-mwge into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 7	N		
XW01X27*	Introduction of Anacaulase-bcdb into Subcutaneous Tissue, External Approach, New Technology Group 7	N		
XW023X7*	Introduction of Tixagevimab and Cilgavimab Monoclonal Antibody into Muscle, Percutaneous Approach, New Technology Group 7	N		
XW03367*	Introduction of Terlipressin into Peripheral Vein, Percutaneous Approach, New Technology Group 7	N		
XW03377*	Introduction of Trilaciclib into Peripheral Vein, Percutaneous Approach, New Technology Group 7	N		
XW03387*	Introduction of Lurbinectedin into Peripheral Vein, Percutaneous Approach, New Technology Group 7	N		
XW033B7*	Introduction of Amivantamab Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 7	N		
XW04367*	Introduction of Terlipressin into Central Vein, Percutaneous Approach, New Technology Group 7	N		
XW04377*	Introduction of Trilaciclib into Central Vein, Percutaneous Approach, New Technology Group 7	N		
XW04387*	Introduction of Lurbinectedin into Central Vein, Percutaneous Approach, New Technology Group 7	N		
XW043B7*	Introduction of Amivantamab Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 7	N		
XW0DXR7*	Introduction of Fostamatinib into Mouth and Pharynx, External Approach, New Technology Group 7	N		
XW0G7R7*	Introduction of Fostamatinib into Upper GI, Via Natural or Artificial Opening, New Technology Group 7	N		
XW0H7R7*	Introduction of Fostamatinib into Lower GI, Via Natural or Artificial Opening, New Technology Group 7	N		
XW133D7*	Transfusion of High-Dose Intravenous Immune Globulin into Peripheral Vein, Percutaneous Approach, New Technology Group 7	N		
XW133F8*	Transfusion of OTL-103 into Peripheral Vein, Percutaneous Approach, New Technology Group 8	N**	PRE	016, 017
XW143D7*	Transfusion of High-Dose Intravenous Immune Globulin into Central Vein, Percutaneous Approach, New Technology Group 7	N		
XXE5XR7*	Measurement of Infection, Mechanical Initial Specimen Diversion Technique Using Active Negative Pressure, New Technology Group 7	N		
XXE5XT7*	Measurement of Intracranial Arterial Flow, Whole Blood mRNA, New Technology Group 7	N		

	Notes:
	(*)-These codes were discussed at the Spring 2026 ICD-10 Coordination and Maintenance Committee meeting and were not finalized in time to include in the proposed rule. They will be invalid effective October 1, 2026.
	(^)-These codes were invalid effective April 1, 2026.
	(**)-Non-OR procedure affects DRGs
